Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Where Rivian Automotive Stands With Analysts

Analysts have provided the following ratings for Rivian Automotive (NASDAQ:RIVN) within the last quarter:

Benzinga

Analyzing Plug Power Inc's Short Interest

Plug Power Inc's (NASDAQ:PLUG) short percent of float has risen 3.11% since its last report. The company recently reported that it has 69.19 million shares sold short, which is 13.61% of all regular shares that are available for trading.

Benzinga

Where Patterson-UTI Energy Stands With Analysts

Patterson-UTI Energy (NASDAQ:PTEN) has observed the following analyst ratings within the last quarter:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Peering Into Starbucks Corporation's Recent Short Interest

Starbucks Corporation's (NASDAQ:SBUX) short percent of float has fallen 5.26% since its last report. The company recently reported that it has 10.36 million shares sold short, which is 0.9% of all regular shares that are available for trading.

Benzinga

Looking At Costco Wholesale's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Costco Wholesale (NASDAQ:COST). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

BMO Capital Maintains Outperform Rating for C4 Therapeutics, Lowers Price Target To $20

BMO Capital has decided to maintain its Outperform rating of C4 Therapeutics (NASDAQ:CCCC) and lower its price target from $57.00 to $20.00. Shares of C4 Therapeutics are trading down 20.49% over the last 24 hours, at $9.00 per share.

Benzinga

Piper Sandler Upgrades Rating to Overweight for ChampionX, Raises Price Target To $30

Piper Sandler upgraded its rating of ChampionX (NASDAQ:CHX) to Overweight with a price target of $30.00, changing its price target from $28.00 to $30.00. Shares of ChampionX are trading down 0.67% over the last 24 hours, at $23.66 per share.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

RBC Capital Maintains Outperform Rating for CoStar Gr, Raises Price Target To $65

RBC Capital has decided to maintain its Outperform rating of CoStar Gr (NASDAQ:CSGP) and raise its price target from $60.00 to $65.00. Shares of CoStar Gr are trading up 0.73% over the last 24 hours, at $63.98 per share.

Benzinga

Baird Downgrades Rating to Neutral for NVIDIA, Lowers Price Target To $225

Baird downgraded its rating of NVIDIA (NASDAQ:NVDA) to Neutral with a price target of $225.00, changing its price target from $360.00 to $225.00. Shares of NVIDIA are trading down 4.75% over the last 24 hours, at $220.21 per share.

Benzinga

Stifel Upgrades Rating to Buy for Photronics, Raises Price Target To $21

Stifel upgraded its rating of Photronics (NASDAQ:PLAB) to Buy with a price target of $21.00, changing its price target from $19.00 to $21.00. Shares of Photronics are trading up 4.48% over the last 24 hours, at $15.16 per share.

Benzinga

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session

Gainers

Benzinga

10 Information Technology Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

10 Health Care Stocks Whale Activity In Today's Session

Benzinga

So What's Up With AMD And Nvidia Shares Falling Today?

NVIDIA Corporation (NASDAQ: NVDA) shares are trading lower after Baird downgraded the stock from Outperform to Neutral and lowered its price target from $360 to $225.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

SVB Leerink Maintains Market Perform Rating for Rubius Therapeutics, Lowers Price Target To $3

SVB Leerink has decided to maintain its Market Perform rating of Rubius Therapeutics (NASDAQ:RUBY) and lower its price target from $5.00 to $3.00. Shares of Rubius Therapeutics are trading down 24.14% over the last 24 hours, at $2.42 per share.

Benzinga

B. Riley Securities Maintains Buy Rating for Silicon Motion Technology, Lowers Price Target To $106

B. Riley Securities has decided to maintain its Buy rating of Silicon Motion Technology (NASDAQ:SIMO) and lower its price target from $135.00 to $106.00. Shares of Silicon Motion Technology are trading down 1.6% over the last 24 hours, at $70.84 per share.

Benzinga

Guggenheim Maintains Buy Rating for Rubius Therapeutics, Lowers Price Target To $5

Guggenheim has decided to maintain its Buy rating of Rubius Therapeutics (NASDAQ:RUBY) and lower its price target from $25.00 to $5.00. Shares of Rubius Therapeutics are trading down 24.14% over the last 24 hours, at $2.42 per share.

Benzinga

HC Wainwright & Co. Maintains Buy Rating for Aadi Bioscience, Lowers Price Target To $48

HC Wainwright & Co. has decided to maintain its Buy rating of Aadi Bioscience (NASDAQ:AADI) and lower its price target from $49.00 to $48.00. Shares of Aadi Bioscience are trading down 4.87% over the last 24 hours, at $16.62 per share.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Oppenheimer Maintains Outperform Rating for BioCryst Pharmaceuticals, Lowers Price Target To $16

Oppenheimer has decided to maintain its Outperform rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) and lower its price target from $20.00 to $16.00. Shares of BioCryst Pharmaceuticals are trading down 1.62% over the last 24 hours, at $10.94 per share.

Benzinga

Credit Suisse Maintains Outperform Rating for Ross Stores, Raises Price Target To $125

Credit Suisse has decided to maintain its Outperform rating of Ross Stores (NASDAQ:ROST) and raise its price target from $118.00 to $125.00. Shares of Ross Stores are trading up 3.27% over the last 24 hours, at $100.01 per share.

Benzinga

Elon Musk To Pump NFTs Next? NFT Creator Beeple Acknowledged By Tesla CEO

Elon Musk — tech tycoon and CEO of electric vehicle manufacturer Tesla Inc. (NASDAQ: TSLA) — clearly started paying attention to the non-fungible token (NFT) industry, as shown by his Twitter Inc. (NYSE:

Benzinga

Kyowa Kirin, Ardelyx Amend Tenapanor Pact In Cardiorenal Disorders

Ardelyx Inc (NASDAQ: ARDX) has

Benzinga

So What's Up With Microsoft Shares Falling Today?

Shares of companies in the broader technology sector, including Microsoft Corporation (NASDAQ: MSFT), are trading lower amid a rise in US Treasury yields.

Benzinga

Analyst Ratings For Goodyear Tire & Rubber

Within the last quarter, Goodyear Tire & Rubber (NASDAQ:GT) has observed the following analyst ratings:

Benzinga

Broadcom Whale Trades Spotted

Someone with a lot of money to spend has taken a bullish stance on Broadcom (NASDAQ:AVGO). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

1 … 707 708 709 710

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.